REDUCED RISK OF CARDIOPULMONARY EVENTS FOR COPD PATIENTS INITIATING BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL VS MULTIPLE INHALER TRIPLE THERAPY IN THE US: THE SKOPOS-MAZI STUDY